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ABSTRACT
Introduction: Diagnosis of peritoneal
tuberculosis (pTB) is difficult, even in
developed countries, where data are lacking.
The aim of the present study was to describe the
clinical presentation, diagnosis, and bacterial
epidemiology of pTB in France over a 10-year
period.
Methods: A retrospective study was conducted
on pTB in two university hospitals in France,
between January 2004 and December 2014.
Results: Among the 34 patients, 76.5% were
migrants from areas of endemic tuberculosis
(TB), mainly Africa. The main presentation
(85.3%) was a checkup of ascites or suspicion
of peritoneal carcinomatosis. On abdominal
computed tomography, ascites was found in
90.6% and peritoneal thickening in 75%.
Surgery was required for diagnosis in 58.8% of
patients. Six of the patients who did not
undergo surgery had ultrasound-guided
peritoneal biopsy. Bacteriology was positive for
ascites in only 58.1% of cases, for peritoneal
biopsy in 73.3%, while granuloma was found in
95.5%. TB polymerase chain reaction (PCR) was
positive in 25% of peritoneal biopsy.
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Mycobacterium bovis was isolated in 23.1% of
cases and Mycobacterium tuberculosis in 76.9%.
Isolates were fully susceptible (except M. bovis
naturally resistant to pyrazinamide). Many
(38%) belonged to the lineage T (genetic
analysis by spoligotyping). Cure rate was high
(76.5%), after a 6–9 months of anti-tuberculous
therapy.
Conclusion: In developed countries, early
diagnosis of pTB is still a challenge.
Ultrasound-guided peritoneal biopsy may
facilitate diagnosis. TB PCR can be useful on
peritoneal biopsy. The lineage T was the most
prevalent lineage, but more data are required to
directly incriminate this lineage in the
pathophysiology of pTB.
Keywords: Ascites; Mycobacterium tuberculosis;
Peritoneal biopsy; Peritoneal tuberculosis;
Spoligotyping; Tuberculous peritonitis
INTRODUCTION
Despite the better control of tuberculosis (TB) in
the world, the proportion of extrapulmonary TB
has increased in recent years [1]. In this context,
peritoneal TB (pTB) represents the most
frequent form of abdominal TB [2]. Data are
lacking in developed countries since most
studies were done in endemic countries of TB
[2–4]. The aim of the present study was to
describe the clinical presentation, diagnosis,
bacterial epidemiology, treatment, and
outcome of pTB in two university hospitals in
France over a 10-year period.
METHODS
All patients diagnosed with pTB in the
university hospitals of Lyon (Croix-Rousse
Hospital) and Nancy (Brabois Hospital)
between January 2004 and December 2014
were included in a retrospective observational
study. France is a country with an incidence of
8.7 per 100,000 population (including 27% of
extrapulmonary) [5] and the two cities Lyon
and Nancy count 1.3 million and 300,000
people, respectively. Patients were identified
by using the database of the administrative
coding system (patients with diagnosis of pTB
in the infectious disease unit) and the database
of the mycobacteriological laboratory of Lyon
and Nancy (patients with a positive culture or
polymerase chain reaction [PCR] of ascites or
peritoneum). Children and patients with
peritonitis due to non-tuberculous
mycobacteria were excluded. Patients without
culture or PCR confirmation of TB but with
peritonitis consistent with pTB based on
clinical, radiographic or histologic evidence
were included. Clinical, imaging and
bacteriological data were collected. Ascites
samples were processed in biosafety level 3
facility as follows: briefly samples were
centrifuged for 15 min before inoculation to
solid (Lo¨wenstein-Jensen) and liquid
(MGIT-Bactec) media. Pellets were heat
inactivated and then used for acid fast bacilli
smear test with fluorescent microscope.
Heat-inactivated samples were further
processed for DNA extraction with MagNA
Pure Roche System and then used for
Mycobacterium tuberculosis specific in house
PCR reaction. Cultured strains were
characterized by spoligotyping (spacer
oligonucleotide typing), a PCR-based method
for genotyping strains [6] and categorized by
lineage, using the SpolDB4 database [7].
Statistical methods used were medians and
percentages.
The study has been approved by the
institutional ethics committee. All procedures
followed were in accordance with the ethical
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standards of the responsible committee on
human experimentation (institutional and
national) and with the Helsinki Declaration of
1964, as revised in 2013. Informed consent
waiver was granted as all data were currently in
existence.
RESULTS
Thirty-four patients were included (29 in Lyon
and 5 in Nancy). There was male predominance,
with 22 men and 12 women; median age was
40 years. Twenty-six patients (76.5%) were
migrants from areas of endemic TB, mainly
Africa. One or more underlying disease was
found in 13 patients (38.2%): liver cirrhosis (6),
diabetes mellitus (6), chronic viral hepatitis (4)
or immunodepression as cancer (4),
immunosuppressive therapy (3) and human
immunodeficiency virus (1, who was already
treated and controlled). HIV was tested for
32/34 patients (94.1%). Two patients (5.9%)
had history of cured TB; history of TB exposure
was reported by seven patients (20.6%). The
main presentation that lead to hospitalization
(29 patients: 85.3%) was a checkup of ascites or
suspicion of peritoneal carcinomatosis; two
patients (5.9%) presented peritonitis. The
main symptoms and signs are given in Table 1.
Four patients (11.8%) presented acute
abdominal illness requiring emergency
laparotomy (two initially and two
secondarily). Median symptom duration before
admission was 1 month.
Biological findings revealed biological
inflammatory syndrome in all patients, with a
median C-reactive protein level of 95 mg/L.
Lymphopenia (under 1.5 G/L) was found in 23
of the 30 patients investigated (76.7%).
Interferon-c release assay (QuantiFERON-TB;
Cellestis) was positive in only 16/22 patients
(72.7%), and 15/24 (62.5%) had positive (at
least 10 mm) tuberculin test (Tubertest; Sanofi
Pasteur). Ascitic fluid analysis found exudate in
17/21 patients (80.1%), with lymphocytic
predominance in 19/21 cases (90.5%).
On abdominal computed tomography (CT),
ascites was found in 29/32 patients (90.6%), and
was the only abnormality in 4/32 of these
(13.8%). Peritoneal, mesenteric, and/or
omentum thickening (Fig. 1) was detected in
24 patients (75%). Only three patients (8.9%)
Table 1 Symptoms and signs at the presentation
(N = 34)
Symptoms n (%)
Fever and/or sweats 24 (70.6%)
Abdominal pain 24 (70.6%)
Ascites or abdominal swelling 19 (55.9%)




Abdominal mass 1 (2.9%)
Salpingitis 1 (2.9%)
Fig. 1 Abdominal computed tomography of a peritoneal
tuberculosis, with peritoneal nodular thickening (white
arrow) and ascites
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had no ascites on CT scan, corresponding to the
‘‘dry plastic’’ form of pTB, defined by Bhargava
[8]. Abdominal ultrasound was equal to CT to
detect ascites (25/28, 89.3%) but less efficient in
detecting peritoneal thickening (6/28, 21.4%).
Six patients (17.8%) had positron emission
tomography, showing increased peritoneal or
mesenteric and lymph node metabolic activity,
which could not be differentiated from
carcinomatosis. Thirty-two out of 34 thoracic
CT (94.1%) were abnormal with pleural effusion
(12), mediastinal lymph node (9), micronodules
(8), nodule (4), or excavation (1). Surgery was
required for diagnosis in 20 cases (58.8%),
including 14 laparoscopies (41.2%) and six
laparotomies (17.6%). Intraoperative visual
inspection was suggestive of pTB in 13
patients (65%), with typical small white
peritoneal granulations or granuloma. Six of
the patients who did not undergo surgery
(42.9%) had ultrasound-guided peritoneal
biopsy. Tuberculous peritonitis was
culture-confirmed in 25 patients. Diagnostic
performance of the various bacteriological and
histological analyses is shown in Table 2. TB
PCR, performed on 13/31 ascites samples and
on 8/14 peritoneal biopsies, was systematically
negative on ascites and positive on only 2
peritoneal biopsies (25%). It should be noted
that a large number of peritoneal biopsies were
not sent to the bacteriology laboratory (8/22,
36.4%), because only malignant ascites was
suspected by the surgeon. Finally, histological
and/or bacteriological diagnostic proof was
obtained in all patients, except for three
(8.8%) who did not have peritoneal biopsy but
were cured by the anti-TB treatment.
Twenty-six infections were documented.
Mycobacterium bovis was isolated in 6 patients
(23.1%) and M. tuberculosis in the others 20
(76.9%). All isolates were susceptible to classical
anti-mycobacterial drugs, except one case of
isoniazid resistance (M. bovis is naturally
resistant to pyrazinamide). Genetic analysis by
spoligotyping, performed in 21 cases, revealed
that 8 (38%) belonged to lineage T (Table 3). T
family lineage is characterized by the absence of
spacers 33–36 among the 43 spacers targeted by
spoligotyping; the prototypic shared
spoligotype is SIT53. There was no specific
clinical characteristic for the spoligotype T.
Sixteen patients (47.1%) showed one or more
other TB location, including lung (five
patients), and digestive (four patients),
gynecological (four patients) and urological
(two patients) tract. Sputum smear
examination or bronchoalveolar lavage was
performed in 32 patients (94.1%) and cultures
Table 2 Diagnostic performance of bacteriological and histological analyses in patients with peritoneal tuberculosis
Ascites Peritoneal biopsy
Total 32 22
Positive culture 58.1% (18/31) 71.4% (10/14)
Positive PCR 0.0% (0/13) 25.0% (2/8)
Total bacteriological performance 58.1% (18/31) 73.3% (11/15)
Histological performance: epithelioid giant-cell granuloma 95.5% (21/22)
Including with caseous necrosis 36.4% (8/22)
PCR polymerase chain reaction
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were positive for 5 patients (14.7%). Extensive
surgery with intestinal resection was required in
two patients because of digestive perforation;
corticosteroids were prescribed for subocclusive
syndrome in two patients; and three
malnourished patients required artificial
nutrition. Median admission-to-treatment time
was 18 days. Antimycobacterial therapy
comprised standard regimen with daily
rifampicin, isoniazid, ethambutol and
pyrazinamide during 2 months followed by at
least 4 months of rifampicin and isoniazid for
24 patients (70.6%); the others had therapy
without pyrazinamide or without isoniazid and/
or with quinolone because of toxicity or hepatic
disorder before treatment. Side-effects led to
dose decrease or a change of treatment in 13
patients (38.2%). Twenty-six patients (76.5%)
completed treatment and were clinically and
radiologically cured; four were lost to follow-up;
one was still under treatment at the time of
writing; and three died during treatment (only
one because of disseminated TB). Median
treatment duration was 8.5 months, and
follow-up without relapse after end of
treatment was 12 months.
DISCUSSION
Early diagnosis of pTB is a challenge as the main
presentation of our cohort (85.3%) was a
checkup of ascites or suspicion of peritoneal
carcinomatosis. Many different clinical
presentations of pTB have been previously
described [3]. Due to non-specific and
insidious symptoms, there is a significant
delay before diagnosis and treatment [4], even
in developed countries. Notably, most cases of
pTB mimic peritoneal carcinomatosis,
especially in women with elevated blood Ca
125 [9]. In cirrhotic patients, pTB can mimic
ascitic decompensation. In addition, imaging
findings may point to carcinomatosis [2]. Thus,
TB should be systematically considered in case
of peritonitis.
Bacteriological performance is imperfect
since culture of ascites was positive in only
58.1% and peritoneal biopsy in 73.3% of cases.
Biopsy for bacterial culture and histology is
essential for diagnosis [10]. Histology allows to
correct the diagnosis of TB in a large number of
cases where bacterial culture was forgotten: it is
essential to routinely do mycobacterial culture
Table 3 Spoligotyping of the 21 strains responsible for peritoneal tuberculosis
Binary description Octal description SIT Label Number of strains
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 703777740003771 26 CAS1_DELHI 1
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 774037777760700 31 T1 1
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 777777607760771 42 LAM9 1
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 777777774020771 47 H1 1
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 777777777760731 52 T2 1
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 777777777760771 53 T1 5
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 777777743760771 61 LAM10_CAM 1
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 777777737760771 86 T1 1
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 674000003413771 89 EAI2_NTB 1
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 777756777760771 302 X1 1
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 676773777777600 482 BOVIS1_BCG 3
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 616773777777600 665 BOVIS1 2
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 777777607760371 1070 U 1
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 703375400001771 / / 1
SIT Spoligo-International-Type number.
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of peritoneal biopsy during an exploration of
ascites or peritoneal thickening, unless there is a
known intra-abdominal malignancy.
Laparoscopic peritoneal biopsy is the reference
method for diagnosis of pTB but, as described
here, ultrasound-guided biopsy may facilitate
diagnosis, with a lower risk of complications
[11]. Culture of ascites fluid must be systematic,
even if the positivity rate is lower than for
peritoneal biopsy, probably because of the low
number of bacilli in the processed samples. In
the present study, TB PCR seemed to be
insensitive when performed on ascites, but can
be useful on peritoneal biopsy [12].
Interestingly, we found that a high
percentage of isolates responsible for pTB
belonged to lineage T. Extrapulmonary TB is
usually more frequently associated with the East
African-Indian or Central-Asian lineages,
whereas lineage T, like the Beijing lineage,
seems to be more frequently linked to
pulmonary forms [13, 14]. The T lineage is the
predominant lineage in Europe, but not in
Africa, where most of our patients have lived
before migrating in France [7]. Finally, it is not
known if particular lineages are more frequently
responsible for pTB and more data are required
to directly incriminate the T lineage in the
pathophysiology of pTB.
In case of suspected pTB, especially with
concordant histology, physicians should not
wait for culture before initiating treatment,
since treatment delay is a very important factor
of poor prognosis [4]. The present cure rate was
high, and there was no relapse during follow-up.
CONCLUSIONS
In developed countries, early diagnosis of pTB is
still a challenge. Ultrasound-guided peritoneal
biopsy may facilitate diagnosis. TB PCR can be
useful on peritoneal biopsy. When histology is
concordant, prompt treatment initiation may
improve prognosis. Data are required to know if
particular lineages are responsible for pTB.
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